Cargando…
Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
Bilastine is a new, well-tolerated, nonsedating H1 receptor antihistamine. In the fasting state bilastine is quickly absorbed, but the absorption is slowed when it is taken with food or fruit juice. Therefore, it is recommended that bilastine is taken at least one hour before and no sooner than two...
Autor principal: | Wolthers, Ole D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728546/ https://www.ncbi.nlm.nih.gov/pubmed/23956994 http://dx.doi.org/10.1155/2013/626837 |
Ejemplares similares
-
Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022) -
Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013) -
Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016) -
Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties
por: Kawauchi, Hideyuki, et al.
Publicado: (2019) -
Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020)